Long-term follow-up of adalimumab monotherapy for rheumatoid arthritis in Japanese patients: a report of six cases

被引：0

作者：

Ichinose, Kunihiro ^{[1
]}

Origuchi, Tomoki ^{[2
]}

Kawashiri, Shin-ya ^{[1
]}

Iwamoto, Naoki ^{[1
]}

Fujikawa, Keita ^{[1
]}

Aramaki, Toshiyuki ^{[1
]}

Kamachi, Makoto ^{[1
]}

Arima, Kazuhiko ^{[1
]}

Tamai, Mami ^{[1
]}

Nakamura, Hideki ^{[1
]}

Ida, Hiroaki ^{[1
]}

Kawakami, Atsushi ^{[1
]}

Eguchi, Katsumi ^{[1
]}

机构：

[1] Nagasaki Univ, Dept Rheumatol, Unit Translat Med, Grad Sch Biomed Sci, Nagasaki 8528501, Japan

[2] Nagasaki Univ, Dept Phys Therapy, Unit Rehabil, Grad Sch Biomed Sci, Nagasaki 8528501, Japan

来源：

RHEUMATOLOGY INTERNATIONAL | 2012年 / 32卷 / 02期

关键词：

Rheumatoid arthritis (RA); Adalimumab; Long-term; DAS28-CRP; ANTITUMOR NECROSIS FACTOR; MONOCLONAL-ANTIBODY; METHOTREXATE; RISK; TUBERCULOSIS; EFFICACY; THERAPY; DISEASE; SAFETY;

D O I：

10.1007/s00296-010-1770-1

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We present six cases of patients with Japanese rheumatoid arthritis (RA) treated with a tumor necrosis factor (TNF)-alpha blocking agent, adalimumab as monotherapy for 220 weeks. All six patients were women, and the median age was 54.0 +/- A 7.07 years old. The median duration of the disease was 7.43 +/- A 11.1 years, and the median disease activity score (DAS28-CRP) was 5.35 +/- A 0.69. Three of six patients were able to continue to receive this treatment for 220 weeks successfully, and the DAS28-CRP decreased to 1.89 +/- A 0.75. Two patients withdrew because of lack of efficacy, and one patient withdrew because of adverse events (non-Hodgkin lymphoma). Adalimumab resulted in a sustained clinical response in RA patients during 220-week follow-up.

引用

页码：483 / 487

页数：5

共 50 条

[41] Alopecia areata: a long-term follow-up study of 104 patients
Lyakhovitsky, A.
Aronovich, A.
Gilboa, S.
Baum, S.
Barzilai, A.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 (08) : 1602 - 1609
[42] Rituximab Therapy in Adults with Refractory Symptomatic Immune Thrombocytopenia: Long-Term Follow-Up of 15 Cases
Hindilerden, Fehmi
Yonal-Hindilerden, Ipek
Yenerel, Mustafa Nuri
Nalcaci, Meliha
Diz-Kucukkaya, Reyhan
TURKISH JOURNAL OF HEMATOLOGY, 2017, 34 (01) : 72 - 80
[43] Treatment of ulcerative colitis with adalimumab or infliximab: long-term follow-up of a single-centre cohort
Gies, N.
Kroeker, K. I.
Wong, K.
Fedorak, R. N.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2010, 32 (04) : 522 - 528
[44] Long-Term Follow-Up and Survivorship
Tsirou, Aimilia
Hjorth, Lars
TUMORS IN ADOLESCENTS AND YOUNG ADULTS, 2016, 43 : 27 - 37
[45] Long-Term Follow-Up of Children Treated With the Modified Atkins Diet
Chen, Wendy
Kossoff, Eric H.
JOURNAL OF CHILD NEUROLOGY, 2012, 27 (06) : 754 - 758
[46] Lipids and Atherogenic Indices Fluctuation in Rheumatoid Arthritis Patients on Long-Term Tocilizumab Treatment
Cacciapaglia, Fabio
Anelli, Maria Grazia
Rinaldi, Angela
Fornaro, Marco
Lopalco, Giuseppe
Scioscia, Crescenzio
Lapadula, Giovanni
Iannone, Florenzo
MEDIATORS OF INFLAMMATION, 2018, 2018
[47] Long-term follow-up for noninvasive body contouring treatment in Asians
Chang, Shyue-Luen
Huang, Yau-Li
Lee, Mei-Ching
Chang, Chih-Hsiang
Lin, Ying-Fang
Cheng, Chun Yu
Hu, Sindy
LASERS IN MEDICAL SCIENCE, 2016, 31 (02) : 283 - 287
[48] Clinical presentation and long-term follow-up of perimyocarditis
Buiatti, Alessandra
Merlo, Marco
Pinamonti, Bruno
De Biasio, Marzia
Bussani, Rossana
Sinagra, Gianfranco
JOURNAL OF CARDIOVASCULAR MEDICINE, 2013, 14 (03) : 235 - 241
[49] Long-term follow-up of nevirapine-treated patients in a single-centre cohort
Colafigli, M.
Di Giambenedetto, S.
Bracciale, L.
Fanti, I.
Prosperi, M.
Cauda, R.
De Luca, A.
HIV MEDICINE, 2009, 10 (08) : 461 - 469
[50] Long-term follow-up of patients with refractory systemic lupus erythematosus during rituximab treatment
Tsanyan, M. E.
Soloviev, S. K.
Torgashina, A. V.
Aleksandrova, E. N.
Radenska-Lopovok, S. G.
Nikolaeva, E. V.
Khrennikov, Ya. B.
Nasonov, E. L.
TERAPEVTICHESKII ARKHIV, 2014, 86 (05) : 40 - 49

← 1 2 3 4 5 →